Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Relypsa Inc (NASDAQ:RLYP)

16.60
Delayed Data
As of 4:00pm ET
 +0.41 / +2.53%
Today’s Change
10.26
Today|||52-Week Range
37.45
-41.43%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$712.8M

Company Description

Relypsa, Inc. operates as a bio-pharmaceutical company focused on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases. Its products include patiromer, a non-absorbed for the treatment of hyperkalemia and RLY6002, polymer drug discovery technology. The company was founded on October 29, 2007 and is headquartered in Redwood City, CA.

Contact Information

Relypsa, Inc.
100 Cardinal Way
Redwood City California 94063
P:(650) 421-9500
Investor Relations:

Employees

Shareholders

Other institutional44.26%
Mutual fund holders41.89%
Individual stakeholders30.03%

Top Executives

John A. OrwinPresident, Chief Executive Officer & Director
Kristine McClintock BallChief Financial Officer & Senior Vice President
Wilhelm StahlChief Technology Officer & Senior Vice President
Lance BermanChief Medical Officer & Senior Vice President
Stephen D. HarrisonChief Scientific Officer & Senior Vice President